4//SEC Filing
REGEN BIOLOGICS INC 4
Accession 0001140361-09-004824
CIK 0000883697operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:38 PM ET
Size
8.5 KB
Accession
0001140361-09-004824
Insider Transaction Report
Form 4
MCNEIL ROBERT G
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2009-02-18$1.80/sh+62,500$112,500→ 74,486 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-02-18−62,500→ 0 totalExercise: $1.80From: 2009-02-17Exp: 2017-10-18→ Common Stock (62,500 underlying)
Footnotes (2)
- [F1]The original exercise price was $0.09 per share of common stock of ReGen Biologics, Inc. (the "Company"); however, after the Company effected a 1 for 20 reverse split of its common stock on November 29, 2008 (the "Reverse Split"), the exercise price became $1.80 per share of common stock.
- [F2]The Company amended Mr. McNeil's Option Agreement dated October 18, 2007 on February 17, 2009 to allow for early exercise of the options issued pursuant to the Option Agreement. The Option Agreement provided for the issuance of 12,500 shares of Series E Preferred Stock of the Company upon exercise, or 62,500 shares of common stock immediately after mandatory conversion of the Series E Preferred Stock and after taking into account the Reverse Split. The Series E Preferred Stock manditorily converted upon effectiveness of the Reverse Split.
Documents
Issuer
REGEN BIOLOGICS INC
CIK 0000883697
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000883697
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 9:38 PM ET
- Size
- 8.5 KB